The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?

Background/Aims: Prognosis assessment in patients with hepatocellular carcinoma (HCC) remains controversial. The most widely used HCC prognostic tool is the Okuda classification, but new staging systems (Cancer of the Liver Italian Program score, Chinese University Prognostic Index, French classific...

Full description

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 40; no. 1; pp. 124 - 131
Main Authors: Cillo, Umberto, Bassanello, Marco, Vitale, Alessandro, Grigoletto, Francesco A, Burra, Patrizia, Fagiuoli, Stefano, D'Amico, Francesco, Ciarleglio, Francesco Antonio, Boccagni, Patrizia, Brolese, Alberto, Zanus, Giacomo, D'Amico, Davide Francesco
Format: Journal Article
Language:English
Published: Oxford Elsevier B.V 2004
Elsevier
Subjects:
Adult
Aged
Aged, 80 and over
Biological and medical sciences
Carcinoma, Hepatocellular - pathology
Cohort Studies
Female
Gastroenterology. Liver. Pancreas. Abdomen
Hepatocellular carcinoma
Humans
Liver function
Liver Neoplasms - pathology
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Neoplasm Staging - methods
Prognosis
Proportional Hazards Models
Retrospective Studies
Staging
Survival Analysis
Therapeutic decision
Tumor stage
Tumors
Tumor stage
Liver function
Hepatocellular carcinoma
Therapeutic decision
Prognosis
Staging
Hepatic disease
Malignant tumor
Treatment
Classification
Gastroenterology
Digestive diseases
Tool
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background/Aims: Prognosis assessment in patients with hepatocellular carcinoma (HCC) remains controversial. The most widely used HCC prognostic tool is the Okuda classification, but new staging systems (Cancer of the Liver Italian Program score, Chinese University Prognostic Index, French classification and Barcelona Clinic Liver Cancer, BCLC, staging) have been recently described. We investigated the value of known prognostic systems in the particular setting of a surgically oriented Liver Unit where 187 HCC Italian patients were mainly treated with radical therapies (resection and percutaneous ablation). Methods: A retrospective analysis of 187 HCCs observed at a single Institution from 1990 and 1999 was performed. By using survival time as the only outcome measure (Kaplan–Meier method and Cox regression), the performance of any prognostic system was assessed according the criteria of discriminatory and stratification abilities between different stages, homogeneity of survival within each stage and additional explanatory power respect to the other classifications. Results: In the particular cohort studied, BCLC proved the best HCC prognostic system. This was true for the whole study group and for the 2 subgroups of surgical and non-surgical patients. Conclusions: BCLC staging showed the best interpretation of the survival distribution in an HCC population comprising a large proportion of tumors treated with potentially radical therapies.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0168-8278
1600-0641
DOI:10.1016/j.jhep.2003.09.027